Fund shareholders of Palisade Bio Inc
ISIN US6963894026 · United States · LEI 549300W6LIDX3I5XXT34
- Fund shareholders
- 12
- Of which ETFs
- 1 11 other funds
- Value held
- 16.3M $
- Share of capital
- 4.9 % of 174.3M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 3,136,607 | 6.3M $ | 0.22 % | 1.80 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2,119,910 | 4.2M $ | 0.41 % | 1.22 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,429,308 | 2.5M $ | 0.00 % | 0.82 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 678,165 | 1.2M $ | 0.00 % | 0.39 % | as of Feb 28, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 350,000 | 612.5K $ | 0.88 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 269,212 | 476.5K $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 230,282 | 407.6K $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 89,915 | 159.1K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 81,764 | 143.1K $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 76,000 | 152K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 32,796 | 65.6K $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 16,454 | 32.9K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.88 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.41 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.22 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 0.02 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | -3 | 8,510,413 | +11.1 % |
| 2026Q1 | 15 | +10 | 7,662,016 | +370.7 % |
| 2025Q4 | 5 | +1 | 1,627,642 | +5,461.2 % |
| 2025Q3 | 4 | 0 | 29,268 | +101.6 % |
| 2025Q2 | 4 | 0 | 14,520 | -0.5 % |
| 2025Q1 | 4 | -1 | 14,588 | -1.8 % |
| 2024Q4 | 5 | 0 | 14,861 | +36.0 % |
| 2024Q3 | 5 | 10,931 |
Institutional managers
91 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| B Group, Inc. | 11,414,285 | 20M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 10,689,452 | 18.8M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 10,276,317 | 18M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 8,928,149 | 15.6M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 8,711,385 | 15.2M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 7,181,062 | 12.6M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 7,124,116 | 12.5M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 5,785,189 | 10.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 5,373,951 | 9.4M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 4,987,499 | 8.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 4,799,875 | 8.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 4,551,533 | 8M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,500,000 | 7.9M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 3,405,757 | 6M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,270,845 | 5.7M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 3,136,607 | 5.5M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 3,000,000 | 5.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,904,911 | 5.1M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,754,403 | 4.8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,500,000 | 4.4M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,333,000 | 4.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 2,264,845 | 4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,103,353 | 3.7M $ | as of Mar 31, 2026 |
| HighVista Strategies LLC | 2,019,326 | 3.5M $ | as of Mar 31, 2026 |
| Artia Global Partners LP | 1,992,367 | 3.5M $ | as of Mar 31, 2026 |
Declared shareholders of Palisade Bio Inc
6 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 9.90 % | 17,620,479 | as of Mar 31, 2026 · SCHEDULE 13G |
| Perceptive Advisors LLC and 2 others | 7.90 % | 14,113,863 | as of Mar 31, 2026 · SCHEDULE 13G |
| Commodore Capital LP and 3 others | 7.20 % | 12,366,776 | as of Mar 31, 2026 · SCHEDULE 13G |
| Soleus Capital Master Fund, L.P. and 5 others | 5.40 % | 9,353,687 | as of May 26, 2026 · SCHEDULE 13G |
| Ameriprise Financial, Inc. and 1 other | 5.30 % | 8,711,385 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.20 % | 411,772 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Palisade Bio Inc". https://titelia.com/en/stocks/palisade-bio-inc-US6963894026